Clinical Trial Update: Metabolic Syndrome and Insulin Resistance at Allina [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating metabolic syndrome and insulin resistance at Allina Health System has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: Allina Health System | Conditions: Metabolic Syndrome | Phase 2 | Status: COMPLETED